Genosyl
Payments companies reported to CMS as associated with Genosyl. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Genosyl, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Genosyl
These are the largest totals companies reported as associated with Genosyl. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mark Twite | Aurora, CO | Pediatric Anesthesiology | $3,690.00 |
| John Mcconnell | Louisville, KY | Pulmonary Disease | $218.53 |
| Puneeta Sarma Vasa | Palo Alto, CA | Anatomic Pathology & Clinical Pathology | $118.45 |
| Tiffany Taylor | Tyler, TX | Neonatal-Perinatal Medicine | $96.58 |
| Cynthia Mcclellan | Tyler, TX | Neonatal (Nurse Practitioner) | $96.58 |
| Renee Gray | Tyler, TX | Acute Care (Nurse Practitioner) | $96.58 |
| Amir Piracha | Louisville, KY | Cardiovascular Disease | $91.45 |
Prescribed Genosyl?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.